THE METABOLISM OF 3'-AZIDO-2',3'-DIDEOXYGUANOSINE IN CEM CELLS

被引:14
|
作者
KARLSSON, A
REICHARD, P
ECKSTEIN, F
机构
[1] KAROLINSKA INST,DEPT VIROL,S-10401 STOCKHOLM 60,SWEDEN
[2] NATL BACTERIOL LAB,DEPT VIROL,S-10521 STOCKHOLM,SWEDEN
[3] MAX PLANCK INST EXPTL MED,CHEM ABT,W-3400 GOTTINGEN,GERMANY
关键词
D O I
10.1016/0006-291X(90)91941-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When CEM cells were incubated with [3H]-labeled 3′-azido-2′,3′-dideoxyguanosine (AzddGuo), the isotope was largely recovered as ribo- and deoxyribonucleotides in the acid soluble fraction of CEM cells, due to extensive catabolism of AzddGuo and recycling of the guanine formed by purine nucleoside phosphorylase. Only 10% was found as the AzddGuo nucleotides, with the diphosphate of AzddGuo as the dominating nucleotide at all time points. Thus nucleoside diphosphate kinase was rate limiting for the formation of AzddGuo triphosphate, responsible for the toxic and antiviral activity of the nucleoside. Inhibition of de novo deoxyribonucleotide synthesis with hydroxyurea increased the phosphorylation of AzddGuo twofold. © 1990.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 50 条
  • [21] COMPARATIVE PHARMACOKINETICS OF 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) AND 3'-AZIDO-2', 3'-DIDEOXYURIDINE (AZDDU) IN MICE
    DOSHI, KJ
    GALLO, JM
    BOUDINOT, FD
    SCHINAZI, RF
    CHU, CK
    DRUG METABOLISM AND DISPOSITION, 1989, 17 (06) : 590 - 594
  • [22] Structure-activity-resistance relationships of 6-modified 3′-azido-2′,3′-dideoxyguanosine nucleotides as inhibitors of HIV-1 reverse transcriptase
    Herman, B. D.
    Obikhod, A.
    Detorio, M.
    Zhang, H-W
    Nettles, J.
    Coats, S. J.
    Schinazi, R. F.
    Mellors, J. W.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A144 - A144
  • [23] Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine
    Agarwal, RP
    Olivero, OA
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 390 (03) : 223 - 231
  • [24] 3'-AZIDO-2',3'-DIDEOXYURIDINE (AZDDU) - COMPARATIVE PHARMACOKINETICS WITH 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) IN MONKEYS
    BOUDINOT, FD
    SCHINAZI, RF
    GALLO, JM
    MCCLURE, HM
    ANDERSON, DC
    DOSHI, KJ
    KAMBHAMPATHI, PC
    CHU, CK
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (02) : 219 - 228
  • [25] ANCHIMERIC ASSISTANCE OF A 5'-O-CARBONYL FUNCTION FOR INVERSION OF CONFIGURATION AT THE 3'-CARBON ATOM OF 2'-DEOXYADENOSINE - SYNTHESIS OF 3'-AZIDO-2',3'-DIDEOXYADENOSINE AND 3'-AZIDO-2',3'-DIDEOXYINOSINE
    HERDEWIJN, PAM
    JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (21): : 5050 - 5053
  • [26] Pharmacokinetics and tissue distribution of (±)-3′-azido-2′,3′-dideoxy-5′-O-(2-bromomyristoyl)thymidine a prodrug of 3′-azido-2′,3′-dideoxythymidine (AZT) in mice
    Parang, K
    Wiebe, LI
    Knaus, EE
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (09) : 989 - 996
  • [28] Substrate mimicry: HIV-1 reverse transcriptase recognizes 6-modified-3′-azido-2′,3′-dideoxyguanosine-5′-triphosphates as adenosine analogs
    Herman, Brian D.
    Schinazi, Raymond F.
    Zhang, Hong-wang
    Nettles, James H.
    Stanton, Richard
    Detorio, Mervi
    Obikhod, Aleksandr
    Pradere, Ugo
    Coats, Steven J.
    Mellors, John W.
    Sluis-Cremer, Nicolas
    NUCLEIC ACIDS RESEARCH, 2012, 40 (01) : 381 - 390
  • [29] Pharmacokinetics of 3 '-azido-2 ',3 '-dideoxy-5-methylcytidine in rats
    Boudinot, F. D.
    Ibrahim, S. S.
    Qin, Y.
    Chu, C. K.
    Schinazi, R. F.
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1990, 1 (06): : 367 - 371
  • [30] EFFECT OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE ON EXPERIMENTAL VIRAL-INFECTIONS
    SHNEIDER, MA
    RUDENKO, NK
    KAVSAN, VM
    BIBILASHVILI, RS
    KRAEVSKII, AA
    KUKHANOVA, MK
    MOLECULAR BIOLOGY, 1987, 21 (03) : 706 - 713